Literature DB >> 25478197

Diagnosis and early detection of COPD using spirometry.

David P Johns1, Julia A E Walters1, E Haydn Walters1.   

Abstract

The standard respiratory function test for case detection of chronic obstructive pulmonary disease (COPD) is spirometry. The criterion for diagnosis defined in guidelines is based on the FEV1/FVC ratio forced expiratory ratio (FER) and its severity is based on forced expiratory volume in one second (FEV1) from measurements obtained during maximal forced expiratory manoeuvres. Spirometry is a safe and practical procedure, and when conducted by a trained operator using a spirometer that provides quality feedback, the majority of patients can be coached to provide acceptable and repeatable results. This allows potentially wide application of testing to improve recognition and diagnosis of COPD, such as for case finding in primary care. However, COPD remains substantially under diagnosed in primary care and a major reason for this is underuse of spirometry. The presence of symptoms is not a reliable indicator of disease and diagnosis is often delayed until more severe airflow obstruction is present. Early diagnosis is worthwhile, as it allows risk factors for COPD such as smoking to be addressed promptly and treatment optimised. Paradoxically, investigation of the patho-physiology in COPD has shown that extensive small airway disease exists before it is detectable with conventional spirometric indices, and methods to detect airway disease earlier using the flow-volume curve are discussed.

Entities:  

Keywords:  Spirometry; case finding; chronic obstructive pulmonary disease (COPD); flow-volume curve

Year:  2014        PMID: 25478197      PMCID: PMC4255165          DOI: 10.3978/j.issn.2072-1439.2014.08.18

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  90 in total

Review 1.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

2.  A century of the mechanics of breathing.

Authors:  Peter T Macklem
Journal:  Am J Respir Crit Care Med       Date:  2004-07-01       Impact factor: 21.405

3.  National survey of spirometer ownership and usage in general practice in Australia.

Authors:  David P Johns; Deborah Burton; Julia A E Walters; Richard Wood-Baker
Journal:  Respirology       Date:  2006-05       Impact factor: 6.424

Review 4.  Gene therapy for alpha-1 antitrypsin deficiency.

Authors:  Terence R Flotte; Christian Mueller
Journal:  Hum Mol Genet       Date:  2011-04-16       Impact factor: 6.150

Review 5.  Therapeutic implications of the pathophysiology of COPD.

Authors:  P T Macklem
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Analysis of the configuration of maximum expiratory flow-volume curves.

Authors:  J Mead
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-02

8.  Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care.

Authors:  Kylie Hill; Roger S Goldstein; Gordon H Guyatt; Maria Blouin; Wan C Tan; Lori L Davis; Diane M Heels-Ansdell; Marko Erak; Pauline J Bragaglia; Itamar E Tamari; Richard Hodder; Matthew B Stanbrook
Journal:  CMAJ       Date:  2010-04-06       Impact factor: 8.262

9.  Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD.

Authors:  Barbara P Yawn; Paul L Enright; Robert F Lemanske; Elliot Israel; Wilson Pace; Peter Wollan; Homer Boushey
Journal:  Chest       Date:  2007-06-05       Impact factor: 9.410

10.  Don't pay for poor quality spirometry tests.

Authors:  Paul Enright; Tjard Schermer
Journal:  Prim Care Respir J       Date:  2013-03
View more
  33 in total

1.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

2.  Computed Tomography Findings of Bronchiectasis in Different Respiratory Phases Correlate with Pulmonary Function Test Data in Adults.

Authors:  Ricardo Holderbaum do Amaral; Carlos S Nin; Vinicius V S de Souza; Giordano R T Alves; Edson Marchiori; Klaus Irion; Gustavo S P Meirelles; Bruno Hochhegger
Journal:  Lung       Date:  2017-03-28       Impact factor: 2.584

3.  Evaluation of symptomatic patients without airflow obstruction: back to the future.

Authors:  Jose Luis Lopez-Campos; Bernardino Alcazar
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Authors:  Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods
Journal:  Eur Respir J       Date:  2019-05-02       Impact factor: 16.671

Review 5.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

6.  Analysis of pulmonary function test results in a health check-up population.

Authors:  Guo Xu; Zhiheng Chen; Xia Cao; Yaqin Wang; Pingting Yang
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

7.  Prognostic implication of FEV1/FVC ratio for limited-stage small cell lung cancer.

Authors:  Oyeon Cho; Young-Taek Oh; Mison Chun; O Kyu Noh; Jae-Sung Heo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

8.  An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.

Authors:  Joshua Keefe; Chen Yao; Shih-Jen Hwang; Paul Courchesne; Gha Young Lee; Josée Dupuis; Joseph P Mizgerd; George O'Connor; George R Washko; Michael H Cho; Edwin K Silverman; Daniel Levy
Journal:  Chest       Date:  2021-07-06       Impact factor: 9.410

Review 9.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

10.  Smoking from a Younger Age Is the Dominant Factor in the Incidence of Chronic Obstructive Pulmonary Disease: Case-Control Study.

Authors:  Winda Safitri; Santi Martini; Kurnia Dwi Artanti; Chung-Yi Li
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.